ArticleEcancermedicalscience2022

Efficacy of cyclin-dependent kinase 4/6 inhibitors in patients with metastatic hormone positive breast cancer: a single institutional study from India.

Sandip Ganguly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.